Venetoclax pharmacokinetics in subjects with end-stage renal disease undergoing hemodialysis

被引:0
|
作者
Noorani, Behnam
Menon, Rajeev
Cen, Xin
Marsh, Kennan
Huang, Weize
Gupta, Shelly
Dobkowska, Edyta
Marbury, Thomas
Salem, Ahmed H.
机构
[1] AbbVie Inc, N Chicago, IL USA
[2] AbbVie Inc, Chicago, IL USA
[3] Genentech Inc, San Francisco, CA USA
[4] Orlando Clin Res Ctr, Orlando, FL USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e19042
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis
    Evans, AM
    Faull, R
    Fornasini, G
    Lemanowicz, EF
    Longo, A
    Pace, S
    Nation, RL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (03) : 238 - 249
  • [22] Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal disease
    Small, D. S.
    Wrishko, R. E.
    Ernest, C. S., II
    Ni, L.
    Winters, K. J.
    Farid, N. A.
    Li, Y. G.
    Brandt, J. T.
    Salazar, D. E.
    Borel, A. G.
    Kles, K. A.
    Payne, C. D.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2009, 34 (05) : 585 - 594
  • [23] Pharmacokinetics of elbasvir and grazoprevir in subjects with end-stage renal disease or severe renal impairment
    Luzelena Caro
    Larissa Wenning
    Hwa-Ping Feng
    Zifang Guo
    Lihong Du
    Pratik Bhagunde
    Christine Fandozzi
    Deborah Panebianco
    William L. Marshall
    Joan R. Butterton
    Marian Iwamoto
    Wendy W. Yeh
    European Journal of Clinical Pharmacology, 2019, 75 : 665 - 675
  • [24] Pharmacokinetics of elbasvir and grazoprevir in subjects with end-stage renal disease or severe renal impairment
    Caro, Luzelena
    Wenning, Larissa
    Feng, Hwa-Ping
    Guo, Zifang
    Du, Lihong
    Bhagunde, Pratik
    Fandozzi, Christine
    Panebianco, Deborah
    Marshall, William L.
    Butterton, Joan R.
    Iwamoto, Marian
    Yeh, Wendy W.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 (05) : 665 - 675
  • [25] Spectrum of echocardiographic abnormalities in end-stage renal disease patients undergoing hemodialysis
    Ostovan, M. A.
    Mazlum, Z.
    Raissjalali, Gh
    Roozbeh, J.
    Sagheb, M.
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2008, 10 (02) : 115 - 117
  • [26] Enterococcus hirae septicemia in a patient with end-stage renal disease undergoing hemodialysis
    J. Gilad
    A. Borer
    K. Riesenberg
    N. Peled
    A. Shnaider
    F. Schlaeffer
    European Journal of Clinical Microbiology and Infectious Diseases, 1998, 17 (8): : 576 - 577
  • [27] Survey of Torus Palatinus in Patients with End-Stage Renal Disease Undergoing Hemodialysis
    Tai, Shao-Yu
    Hsu, Chia-Lin
    Tsai, Aileen I.
    Chang, Chih-Chun
    Wang, I-Kuan
    Weng, Cheng-Hao
    Huang, Wen-Hung
    Hsu, Ching-Wei
    Chang, Pei-Ching
    Yen, Tzung-Hai
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [28] Enterococcus hirae septicemia in a patient with end-stage renal disease undergoing hemodialysis
    Gilad, J
    Borer, A
    Riesenberg, K
    Peled, N
    Shnaider, A
    Schlaeffer, F
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1998, 17 (08) : 576 - 577
  • [29] Hemodialysis in children with end-stage renal disease
    Dominik Müller
    Stuart L. Goldstein
    Nature Reviews Nephrology, 2011, 7 : 650 - 658
  • [30] Vitamins E & C in patients with end-stage renal disease undergoing hemodialysis
    Smith, KS
    Ridlington, JW
    Leonard, SW
    Mitchel, N
    Traber, MG
    FASEB JOURNAL, 2002, 16 (05): : A989 - A989